Fred Alger Management’s Akebia Therapeutics AKBA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$244K	Buy	+67,013	New	+$244K	﹤0.01%	422
2020 Q3	–	Sell	-90,000	Closed	-$1.22M	–	460
2020 Q2	$1.22M	Buy	90,000 +35,000	+64%	+$475K	﹤0.01%	334
2020 Q1	$417K	Buy	+55,000	New	+$417K	﹤0.01%	367